Thomas Hermanns, Marian S Wettstein, Basil Kaufmann, Noémie Lautenbach, Ernest Kaufmann, Karim Saba, Florian A Schmid, Andreas M Hötker, Michael Müntener, Martin Umbehr, Cédric Poyet
OBJECTIVES: To develop a novel biopsy prostate cancer (PCa) prevention calculator (BioPrev-C) using data from a prospective cohort all undergoing mpMRI targeted and transperineal template saturation biopsy. MATERIALS AND METHODS: Data of all men who underwent prostate biopsy in our academic tertiary care center between 11/2016 and 10/2019 was prospectively collected. We developed a clinical prediction model for the detection of high-grade PCa (Gleason score ≥7) based on a multivariable logistic regression model incorporating age, PSA, prostate volume, digital rectal examination, family history, previous negative biopsy, 5-alpha-reductase inhibitor use and MRI PI-RADS score...
2024: Frontiers in Oncology